Evonik Industries (FRA:EVK) Given a €21.00 Price Target by UBS Group Analysts

Evonik Industries (FRA:EVK) has been given a €21.00 ($24.42) price objective by research analysts at UBS Group in a report released on Monday, February 4th, www.boersen-zeitung.de reports. The firm presently has a “sell” rating on the stock. UBS Group’s target price suggests a potential downside of 15.76% from the company’s current price.

EVK has been the subject of a number of other reports. Societe Generale set a €40.00 ($46.51) price objective on shares of Evonik Industries and gave the company a “buy” rating in a research note on Tuesday, November 6th. Sanford C. Bernstein set a €32.00 ($37.21) price objective on shares of Evonik Industries and gave the company a “buy” rating in a research note on Tuesday, January 8th. Credit Suisse Group set a €31.30 ($36.40) price objective on shares of Evonik Industries and gave the company a “buy” rating in a research note on Wednesday, November 7th. equinet set a €41.00 ($47.67) price objective on shares of Evonik Industries and gave the company a “buy” rating in a research note on Tuesday, November 6th. Finally, JPMorgan Chase & Co. set a €24.50 ($28.49) price objective on shares of Evonik Industries and gave the company a “neutral” rating in a research note on Thursday, January 10th. Four analysts have rated the stock with a sell rating, six have issued a hold rating and twelve have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of €30.68 ($35.67).

EVK traded up €0.18 ($0.21) on Monday, reaching €24.93 ($28.99). The company had a trading volume of 673,019 shares. Evonik Industries has a one year low of €26.78 ($31.14) and a one year high of €32.97 ($38.34).

About Evonik Industries

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.

See Also: What is a stock buyback?

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply